According to federal health officials,
one-third of primary care doctors and nurses in the U.S. are unaware
Truvada is the once-daily pill that the
Centers for Disease Control and Prevention (CDC) says offers 90
percent protection to gay men at risk of acquiring HIV from sex when
taken as prescribed.
Truvada is the brand name for the
treatment known as pre-exposure prophylaxis, or PrEP. It is
currently the only such drug approved by the Food and Drug
Administration for PrEP.
“Providers play a central role in
increasing awareness and uptake of PrEP,” Dr. Eugene McCray,
director of the CDC's division of HIV prevention, is quoted as saying
New York Times.
The findings were released last week,
ahead of World AIDS Day, which takes place Tuesday, December 1.